|
| 37802138 | The Impact of Ejection Fraction on Major Adverse Limb Events after Lower Extremity Revascularization. | Ann Vasc Surg | 2024 |
| 36115521 | Association of depression and anxiety disorders with outcomes after revascularization in chronic limb-threatening ischemia hospitalizations nationwide. | J Vasc Surg | 2023 |
| 37919968 | Comparative Analysis of Mortality and Amputation Rates in Patients Undergoing Atherectomy for Infra-Popliteal Peripheral Arterial Disease: Insight From the VQI. | J Endovasc Ther | 2023 |
| 37648091 | The Vascular Quality Initiative assessment of the Bard Lifestent for the treatment of popliteal artery occlusive disease. | J Vasc Surg | 2023 |
| 37781785 | Association Between Mental Health Burden, Clinical Presentation, and Outcomes in Individuals With Symptomatic Peripheral Artery Disease: A Scientific Statement From the American Heart Association. | Circulation | 2023 |
| 37879802 | Artificial Intelligence, Computational Simulations, and Extended Reality in Cardiovascular Interventions. | JACC Cardiovasc Interv | 2023 |
| 37638882 | Patient knowledge and preferences for peripheral artery disease treatment. | Vasc Med | 2023 |
| 36948738 | Integrating Psychosocial Care in the Management of Patients With Vascular Disease. | J Am Coll Cardiol | 2023 |
| 37385170 | Representativeness of Peripheral Artery Disease Randomized Clinical Trials Supporting Current Guidelines. | Am J Cardiol | 2023 |
| 36944389 | Community distress and risk of adverse outcomes after peripheral vascular intervention. | J Vasc Surg | 2023 |
| 37470195 | Longitudinal Pathways Between Physical Activity, Depression, and Perceived Stress in Peripheral Artery Disease. | Circ Cardiovasc Qual Outcomes | 2023 |
| 37309164 | Predictors of Revascularization in Lower-Extremity Peripheral Artery Disease: Insights From the PORTRAIT Study. | J Endovasc Ther | 2023 |
| 37207790 | Comparison of lower extremity bypass and peripheral vascular intervention for chronic limb-threatening ischemia in the Medicare-linked Vascular Quality Initiative. | J Vasc Surg | 2023 |
| 36974774 | Drug-Coated Balloon and Drug-Eluting Stent Safety in Patients With Femoropopliteal and Severe Chronic Kidney Disease. | J Am Heart Assoc | 2023 |
| 37167558 | In-home Visits and Subsequent Health Outcomes in Medicare Advantage Beneficiaries With Coronary Artery Disease, Diabetes, Hypertension, and Depression. | Med Care | 2023 |
| 37225553 | Obesity prevalence and variability in management practices for patients with symptomatic peripheral artery disease. | Obes Res Clin Pract | 2023 |
| 37293740 | The problem of disparities in vascular health. | Vasc Med | 2023 |
| 37293738 | Lower extremity symptoms and ankle-brachial index screening as predictors of cardiovascular outcomes in Black adults. | Vasc Med | 2023 |
| 36444513 | Health status and cognitive function for risk stratification in chronic coronary and peripheral artery disease. | Eur J Prev Cardiol | 2023 |
| 36577485 | Real-world abdominal aorta aneurysm screening patterns among patients with new or worsening of symptomatic peripheral artery disease. | Int J Cardiol | 2023 |
| 36710497 | Use of drug-coated balloons and stents in patients with femoropopliteal artery disease and severe chronic kidney disease. | Vasc Med | 2023 |
| 36708037 | The use of evidence-based medical therapy in patients with critical limb-threatening ischaemia. | Eur J Prev Cardiol | 2023 |
| 36792257 | Guideline-Directed Medical Therapy and Long-Term Mortality and Amputation Outcomes in Patients Undergoing Peripheral Vascular Interventions. | JACC Cardiovasc Interv | 2023 |
| 36524895 | Correlation between reflux time and venous clinical severity score in patients undergoing saphenous vein ablation: A prospective study. | Phlebology | 2023 |
| 36179780 | The association of depression with mortality and major adverse limb event outcomes in patients with peripheral artery disease: A systematic review and meta-analysis. | J Affect Disord | 2023 |
| 36245106 | Variability in Antithrombotic Therapy after Infrainguinal Lower Extremity Bypass. | Ann Vasc Surg | 2023 |
| 36037965 | Risk profiles, access to care, and outcomes in Hispanics hospitalized for lower extremity peripheral artery disease. | J Vasc Surg | 2023 |
| 34627824 | Peripheral Artery Disease and COVID-19 Outcomes: Insights from the Yale DOM-CovX Registry. | Curr Probl Cardiol | 2022 |
| 37791014 | Peripheral Artery Disease Screening in the Community and 1-Year Mortality, Cardiovascular Events, and Adverse Limb Events. | AJPM Focus | 2022 |
| 35803459 | The Impact of Clinical Follow-Up After Revascularization on the Outcomes of Patients with Chronic Limb Threatening Ischemia. | Ann Vasc Surg | 2022 |
| 35673949 | Statins and statin intensity in peripheral artery disease. | Vasa | 2022 |
| 35579010 | One-Year Health Status Outcomes Following Early Invasive and Noninvasive Treatment in Symptomatic Peripheral Artery Disease. | Circ Cardiovasc Interv | 2022 |
| 35603755 | Variability in 30-day major amputation rates following endovascular peripheral vascular intervention for critical limb ischemia. | Vasc Med | 2022 |
| 35485400 | Frailty and outcomes following revascularization of lower-extremity peripheral artery disease: Insights from the Vascular Quality Initiative (VQI). | Vasc Med | 2022 |
| 35618351 | Call for Formalized Pathways in Vascular Medicine Training: JACC Review Topic of the Week. | J Am Coll Cardiol | 2022 |
| 36342173 | Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia. | N Engl J Med | 2022 |
| 35868423 | Patient-level and external factors in the use of drug-coated balloons and drug-eluting stents in femoropopliteal endovascular interventions. | J Vasc Surg | 2022 |
| 36204596 | Telehealth care before and during COVID-19: trends and quality in a large health system. | JAMIA Open | 2022 |
| 35863439 | Antiplatelet regimens following carotid artery revascularization. | Am Heart J | 2022 |
| 36129818 | Real-world VASCADE closure device versus manual compression use and outcomes in patients with severe common femoral artery disease. | Catheter Cardiovasc Interv | 2022 |
| 35926786 | Major Adverse Limb Events Among Patients with Premature Peripheral Artery Disease Compared with Those at the Common Age Undergoing Revascularization in the Vascular Quality Initiative. | Ann Vasc Surg | 2022 |
| 36256655 | Derivation and validation of a predictive model for chronic stress in patients with cardiovascular disease. | PLoS One | 2022 |
| 36252117 | Advancing Peripheral Artery Disease Quality of Care and Outcomes Through Patient-Reported Health Status Assessment: A Scientific Statement From the American Heart Association. | Circulation | 2022 |
| 35132874 | Association of Disease-Specific Health Status With Long-Term Survival in Peripheral Artery Disease. | J Am Heart Assoc | 2022 |
| 35181520 | The Nevada peripheral artery disease screening effort in a Medicare Advantage population and subsequent mortality and major adverse cardiovascular event risk. | J Vasc Surg | 2022 |
| 35114067 | Impact of malnutrition and frailty on mortality and major amputation in patients with CLTI. | Catheter Cardiovasc Interv | 2022 |
| 35201804 | The Yale Roadmap for Health Psychology and Integrated Cardiovascular Care. | Health Psychol | 2022 |
| 35198727 | The shifting care and outcomes for patients with endangered limbs - Critical limb ischemia (SCOPE-CLI) registry overview of study design and rationale. | Int J Cardiol Heart Vasc | 2022 |
| 34793986 | Patient representativeness of a peripheral artery disease cohort in a randomized control trial versus a real-world cohort: The CLEVER trial versus the PORTRAIT registry. | Contemp Clin Trials | 2022 |
| 34610776 | Trends in drug-coated device use for peripheral artery disease: Insights from the Vascular Quality Initiative (VQI). | Vasc Med | 2022 |